Financials data is unavailable for this security.
View more
Year on year Topco Scientific Co Ltd 's revenues fell -6.99% from 52.98bn to 49.27bn. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 3.02bn to 2.84bn, a -6.08% decrease.
Gross margin | 13.60% |
---|---|
Net profit margin | 6.34% |
Operating margin | 7.11% |
Return on assets | 10.00% |
---|---|
Return on equity | 21.57% |
Return on investment | 17.24% |
More ▼
Cash flow in TWDView more
In 2023, Topco Scientific Co Ltd increased its cash reserves by 21.55%, or 1.15bn. The company earned 1.62bn from its operations for a Cash Flow Margin of 3.29%. In addition the company generated 1.49bn cash from financing while 1.91bn was spent on investing.
Cash flow per share | 19.79 |
---|---|
Price/Cash flow per share | 15.30 |
Book value per share | 88.95 |
---|---|
Tangible book value per share | 86.89 |
More ▼
Balance sheet in TWDView more
Current ratio | 1.45 |
---|---|
Quick ratio | 1.12 |
Total debt/total equity | 0.3053 |
---|---|
Total debt/total capital | 0.2316 |
More ▼
Growth rates in TWD
Year on year, growth in dividends per share marginally increased 0.92% while earnings per share excluding extraordinary items fell by -7.74%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg) | 5.93% |
---|---|
Div growth rate (5 year) | 13.75% |
Payout ratio (TTM) | 56.06% |
EPS growth(5 years) | 14.60 |
---|---|
EPS (TTM) vs TTM 1 year ago | 16.97 |
More ▼